This challenge is underscored by contrasting results across animal studies, where some medications, such as insulin, show promise in controlling blood glucose and promoting bone healing, while others, like sitagliptin, fail to overcome the detrimental effects of sustained hyperglycemia. Here, INS is linked to Hyperglycemia.